Cancer Stem Cells and Somatic Stem Cells as Potential New Drug Targets, Prognosis Markers, and Therapy Efficacy Predictors in Breast Cancer Treatment

New drug targets, markers of disease prognosis, and more efficient treatment options are an unmet clinical need in breast cancer (BC). We have conducted a pilot study including patients with luminal B stage breast cancer IIA–IIIB. The presence and frequency of various populations of cancer stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Pershina, Olga, Ermakova, Natalia, Pakhomova, Angelina, Widera, Darius, Pan, Edgar, Zhukova, Mariia, Slonimskaya, Elena, Morozov, Sergey G., Kubatiev, Aslan, Dygai, Alexander, Skurikhin, Evgenii G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467941/
https://www.ncbi.nlm.nih.gov/pubmed/34572409
http://dx.doi.org/10.3390/biomedicines9091223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467941/
https://www.ncbi.nlm.nih.gov/pubmed/34572409
http://dx.doi.org/10.3390/biomedicines9091223

Ejemplares similares